Literature DB >> 13563166

Thrombolysis with fibrinolysin (plasmin)-new therapeutic approach to thromboembolism.

K M MOSER.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN/therapeutic use; THROMBOEMBOLISM/therapy

Mesh：

Substances：

Year:  1958        PMID： 13563166     DOI： 10.1001/jama.1958.02990310001001

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  8 in total

1.  Fibrinolytic treatment of coronary thrombosis. A pilot study.

Authors:  H A DEWAR; A R HORLER; A J CASSELLS-SMITH
Journal:  Br Med J       Date:  1961-09-09

2.  The present status of the clinical evaluation of fibrinolysin.

Authors:  R V CHAPPLE; H O SINGHER
Journal:  Can Med Assoc J       Date:  1959-08-15       Impact factor: 8.262

3.  Anticoagulant therapy in cerebrovascular disease.

Authors:  J MARSHALL; D A SHAW
Journal:  Proc R Soc Med       Date:  1959-07

4.  Chymotrypsin in cataract surgery.

Authors:  H REED
Journal:  Can Med Assoc J       Date:  1960-04-09       Impact factor: 8.262

5.  Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes.

Authors:  M HUME; W W GLENN; T GRILLO
Journal:  Ann Surg       Date:  1960-04       Impact factor: 12.969

6.  The successful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin.

Authors:  G D HOWDEN
Journal:  Can Med Assoc J       Date:  1959-09-01       Impact factor: 8.262

7.  Lysis of a Cerebral Thrombus with Fibrinolysin: A Case Report.

Authors:  F P McBroom
Journal:  J Natl Med Assoc       Date:  1963-07       Impact factor: 1.798

8.  A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Authors:  R D Shlansky-Goldberg; A H Matsumoto; G A Baumbach; J B Siegel; R D Raabe; T P Murphy; C Deng; J Ray Dawkins; V J Marder
Journal:  J Thromb Haemost       Date:  2008-04-02       Impact factor: 5.824
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.